A new immunotherapy, tested for the blood cancer acute lymphoblastic leukemia (ALL), demonstrated impressive results in early clinical trials, of among several dozen patients.
Read more at Drug Discovery & Development.
Related Articles Read More >
DoMore Diagnostics and Proscia partner to inform personalized treatment decisions for colorectal cancer patients
R&D 100 winner of the day: Siemens Healthineers Intelligent Emergency Imaging
Novel nanomaterial air purification beats HEPA at filtering contaminants and pathogens
